FS Development Corp. II (FSII) to Combine with Pardes Biosciences in $657M Deal

FS Development Corp. II (FSII) to Combine with Pardes Biosciences in $657M Deal


Warning: DOMDocument::loadHTML(): Unexpected end tag : p in Entity, line: 5 in /var/convesio/wordpress/wp-content/plugins/spacinsider-upqode/src/Start.php on line 90

FS II (NASDAQ:FSII) has entered into a definitive agreement to combine with biotech researcher Pardes at an equity value of $657 million. California-based Pardes is developing two pre-clinical drug candidates that have potential treatment applications against COVID-19. The combined company is expected to trade on the Nasdaq under the symbol “PRDS” once the deal closes
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.